Endothelin receptor antagonists in cardiology clinical trials.
about
Up-regulation of endothelin type B receptors in the human internal mammary artery in culture is dependent on protein kinase C and mitogen-activated kinase signaling pathwaysPropeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study.
P2860
Endothelin receptor antagonists in cardiology clinical trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Endothelin receptor antagonists in cardiology clinical trials.
@ast
Endothelin receptor antagonists in cardiology clinical trials.
@en
Endothelin receptor antagonists in cardiology clinical trials.
@nl
type
label
Endothelin receptor antagonists in cardiology clinical trials.
@ast
Endothelin receptor antagonists in cardiology clinical trials.
@en
Endothelin receptor antagonists in cardiology clinical trials.
@nl
prefLabel
Endothelin receptor antagonists in cardiology clinical trials.
@ast
Endothelin receptor antagonists in cardiology clinical trials.
@en
Endothelin receptor antagonists in cardiology clinical trials.
@nl
P2093
P2860
P1476
Endothelin receptor antagonists in cardiology clinical trials.
@en
P2093
Richard Pacher
Rudolf Berger
Thomas Neunteufl
P2860
P304
P356
10.1517/13543784.11.3.431
P407
P577
2002-03-01T00:00:00Z